Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protective Effect of Ulinastatin Against Negative Inflammatory Response and Organ Dysfunction After Acute Type a Aortic Dissection Surgery (PANDA I)

NCT04711889 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.

NCT NCT04711889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04711889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protective Effect of Ulinastatin Against Negative Inflammatory Response and Organ Dysfunction After Acute Type a Aortic Dissection Surgery (PANDA I)
Lead sponsor
Nanjing Medical University
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2021
Completion date
June 30, 2022
Enrollment
203 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute aortic syndrome, type a aortic dissection